BPC-157
HealingResearch only — not approvedBody Protection Compound · PL 14736
A gastric pentadecapeptide studied for tissue repair. Commonly logged as a daily or twice-daily subcutaneous research compound.
- Typical form
- Lyophilized vial
- Typical route
- Subcutaneous
- Display unit
- mcg
- Typical vial
- 5 mg
- Half-life (approx.)
- 4 h
- Default in-use window
- 28 days
Educational · commonly logged
Typical protocol
A snapshot of how this compound is logged — not a prescription. You set every number.
- Common range
- 250–500 mcg
- Starting log
- 250 mcg
- Cadence
- Daily
- Timing
- Morning, or split morning/evening
- Duration
- 4–8 week cycles in community logs
Daily or twice-daily SubQ is the usual log shape. Split 250 mcg BID is as common as a single 500 mcg draw.
Reconstitution note
5 mg + 2 mL BAC → 2.5 mg/mL. 250 mcg is 10 units on a U-100.
Storage
Lyophilized: fridge or freezer. Reconstituted with BAC: refrigerate, do not freeze, typical 28-day in-use window.
Cautions
Not FDA-approved. Injection-site irritation is the most commonly logged complaint. Do not present as a treatment.
Evidence posture
Most evidence is preclinical. Human data are limited and not an approved indication.